The new COVID vaccine is important as last year's shot is less effective against new variants, with protection decreasing over time, leading FDA advisers to recommend a new shot.
FDA advisers unanimously voted for a new vaccine to target the evolving coronavirus variant JN.1, with Pfizer and Moderna ready to provide updated vaccines by August pending FDA approval.
[
Collection
]
[
|
...
]